INTRAGAM – SUPPLY AND SAFETY
From the address by DR ERICA WOOD, Transfer Medical
Specialist, Australian Red Cross Blood Service, to the IN Group
Public Meeting, held Wednesday 13th February 2002 at
the Balwyn Library Meeting Room, 336 Whitehorse Road, Balwyn.
I am a haematologist with a number of interests but intravenous
gammaglobulin (IVIG – CSL tradename Intragam) is not my particular
speciality. I have an interest in blood safety and I do some work
with The World Health Organisation. Professor Boyce is our Intragam
specialist but a lot of my work on a day-to-day basis is talking
to doctors, hospitals, nurses and sometimes to patients about Intragam
and its uses.
Intragam P is the current product available – intravenous gammaglobulin
is its scientific name. Basically it is a fractionated plasma product.
We collect blood plasma from blood donors and then we prepare the
plasma fraction from that, using a variety of means. What we end
up with is a very small amount of immunoglobulin, the antibodies
from the original donations. All the Intragam comes from Australian
blood donors. We don’t have any synthetic way of making it, or making
it from animals.
The term anion-exchange chromatographic technology platform is
the term that explains how we get our Intragam. In the past we used
to use a technique called cone fractionation. The new method is
more sophisticated, gentle and efficient – a 10% increase in output.
Intragam P has two viral inactivation steps. One is a pasteurisation,
heating the Intragam at 60 degrees C for 10 hours. The second step
is incubation at low ph (very acidic). These steps are to inactivate
viruses that could be transmitted through plasma. Intragam is an
extremely safe product. Since these steps were introduced there
has been no transmission of any viral infections in Australia from
Intragam. Intragam is probably one of the safest IVIGs in the world.
The most important way that we ensure the safety of the Intragam
that comes from CSL is to choose our blood donors carefully. The
questionnaire that we ask of our blood donors that come to the Australian
Red Cross is four pages long. We ask the most incredibly personal
questions, some of which embarrass all sorts of people. But we need
to know a lot about what people have done in their past lives which
may or may not make them eligible to be a blood donor. Our blood
donors are volunteers. They come because they feel a sense of altruism,
a sense of community service. The blood is not going to somebody
they know necessarily. Because they are not getting any personal
reward, we can rely on their honesty when they answer the questionnaire.
Before we had any tests for hepatitis, HIV (aids virus), this asking
people the right questions about risk behaviours in their past was
the way that the rate of HIV transmission through blood transfusion
was decreased very dramatically. This was much more effective, surprisingly,
than having a test for HIV. So we rely on those kinds of donor screening
questions as the first step in the safety of our IVIG.
After collection the blood is separated into its fractions – the
red cells, the platelets, the plasma. The plasma is sent to CSL
for fractionation. It goes through this anion process to end up
as Intragam. When we send the blood to CSL it has already been tested
by the Red Cross for Hepatitis B and C, HIV and a number of other
things. CSL then tests it again after recept. Then we know the steps
involved in making Intragam remove lots of potential viruses, should
there have been any that we didn’t detect on testing. We go to extreme
lengths to ensure the plasma we send to CSL for fractionation is
safe and the Intragam for treatment that results is safe. All of
this comes from a volunteer donor, so we need to rely on the screening
mechanisms to make sure the blood is safe. Anything that comes from
a human being has a potential to transmit disease to another human
being. CSL is involved in a lot of research to work out what things
could be transmitted through blood that might be of relevance to
the people receiving the Intragam.
- Do you lose any of the plasma you collect through such processing?
A. We lose quite a lot. This new chromatographic processing has
increased the yield by some 10%. We still don’t get out 100% of
the proteins that we put in, we get out about 40/50%.
Most of the Intragam goes to support people with immune deficiencies,
either congenital – you are born with the deficiency as a child
and we can give you Intragam that contains antibodies to make up
for those you can’t produce. Secondary immune deficiencies are also
very common, sometimes related to haematological problems that come
on later in life and cause inability to produce adequate quantities
of antibodies and risks of infection. A large number of people suffer
from neurological disease such as GBS and CIDP and these receive
some 25% of the Intragam output.
Categories of appropriateness of therapy by Intragam have been
established by the Review of the AHMAC Working Committee. Category
1 is where there is convincing evidence that treatment by Intragam
is likely to be beneficial. (GBS and CIDP are so categorised.) Category
2 refers to conditions where there is some evidence, but not conclusive,
that it may be beneficial. Category 3 is where there is no convincing
evidence.
This latter is a very vexed area. How much evidence do you need
to start treating somebody with Intragam? If you treat more disorders
of this last category, will you gather evidence that it may or may
not be helpful. Most of the Category 1 disorders for which we now
have good evidence probably started off without such evidence. It
is because we gather that kind of data, not just here but internationally,
about how IVIG works in different conditions that we can build up
the data base of whether it is likely to be effective. For rare
disorders it may take thousands of people to be treated to really
know whether people benefit or not.
Q. Why have some asthma sufferers been treated with Intragam?
A. There are some case reports that some steroid resistant asthma
sufferers do extremely well with Intragam. But this should be done
as a clinical trial. Where there are new or emerging indications
we would like to encourage clinicians to enrol their patients in
a clinical trial. A problem is that Australia has a small, spread-out
population. On the other hand we have a very sophisticated medical
system and people are very interested in doing research. Some of
the conditions are quite rare and so in Australia it can be quite
difficult to get enough cases. For this reason many studies have
been done overseas.
It is not only the new indications of likely benefit from Intragam;
there is also the situation we have a growing, aging population.
Many of the diseases are ones of later life and we don’t have enough
Intragam to go around. But we know that we are trying to increase
the amount of plasma that goes to CSL for fractionation. Each year
the Australian Red Cross has been able to increase the amount of
plasma that goes to CSL to make Intragam – last year se sent nearly
250kg of plasma.
It is important to remember that a lot of the plasma donated is
needed to treat people without being fractionated – just as raw
plasma for burns victims, people with coagulation disorders. It
is frozen and then released for transfusion. We have to strike a
balance between CSL fractionation and transfusion. The demand for
transfusions is also increasing.
Q. How many people are eligible for donating blood?
A. About 3-5%.
We have estimated that the amount of blood needed for fractionation,
given the current requirements, the Australian population and international
expectations, is probably 50kg of raw plasma per million of population.
This works out at about 900kg. At the moment we are sending 250kg.
It all costs money to increase the supply – increase more blood
donors, more staff to collect more blood, etc. As you know we cannot
presently meet the demand, on a good day about 80% of the requests.
For every litre of donated raw plasma we get about 3gm of Intragam.
Many doctors and patients would like to receive a dosage of 2gm/kg
patient weight on a regular basis. So if you are the average weight
of 70kg you are going to need the equivalent of 47 litres of plasma
from 200 donations for the needed Intragam. We set the safe limit
of 0.5litre for a blood donation (about 10% of the person’s blood).
We treat every donor with respect and consideration – we also look
forward to future donations! The blood donated is quickly regenerated
– to be achieved by drinking plenty of fluids before and after donation.
Blood is collected in cities and many towns throughout Australia
and the plasma for fractionation goes to CSL. In Melbourne we have
collection centres in Bundoora, Bourke Street and Southbank. We
also go out in the community and set up in church and school halls.
We have blood drives in hospitals – hospital staff are amongst our
most loyal supporters. We want to make it easy for people to donate
blood.
CSL, as well as processing plasma for the Australian requirements,
also processes for some SE Asian countries. CSL receives the plasma
from these countries and returns them the processed Intragam.
Q. Most of our members are prescribed very much less than the
2m/kg Intragam for their GBS and CIDP, usually say 30gm (and they
usually only get say 24gm).
A. There are many conditions where we will try and give a very
large first dose and then go to some maintenance monthly dose. We
certainly can’t support 2mg/kg on a regular basis for most people.
Q. What can be done to improve donations?
A. Advertising is a basic way but there are lots of other ways.
Community networking and support is very powerful. Many people come
to the Red Cross and say they have decided to be a blood donor.
We say "Thanks very much". They have usually decided this
because they know somebody who needed a blood transfusion. This
is one of the most powerful ways of attracting donors. People’s
families can be very committed in this way, not thinking about donating
until the need has become personal.
Q. Some years ago the Commonwealth Government stopped giving
their staff time-off to donate blood. Is there any chance of a change
of policy?
A. This may well have happened. A lost of companies will give time
out to their staff to give blood but it is very hard to require
that. We do endeavour to make it easier for people to come, not
in the middle of their work day, can we open earlier or later, on
weekends.
One of the problems is to know when people will come. So we encourage
people to make appointments, particularly at our permanent locations.
Q. One recommendation by the AHMAC Working Party that the Government
did not accept was to provide $14 million extra to overcome the
Intragam short fall? How important is money?
A. Money is one part of it. It would certainly be nice to have
more staff, more occasions for people to donate, more places for
people to go.
Q. Do you have a schools’ program?
A. Yes, we do. Quite a lot of our blood comes from young people.
We have a program for the last year with the "Herald-Sun"
to increase the awareness and importance of blood donations in schools.
Young people are very open, many are community minded but many would
never have thought of being a blood donor if somebody had not put
that information to them. We have also blood drives in universities.
(The In group has taken part in the Blood Service Summer Challenge
for the past two years, Ed)
Q. My brother is a teacher at Ballarat and being aware of my
condition he has encouraged kids at his school to donate blood.
This year they are getting in competition with other schools.
A. It has been very successful. We have been delighted with the
uptake from young people. We know the hardest thing is for somebody
to become a donor for the first time. People are too busy; I don’t
like needles. Once you get people to come in the first time, it
is not as scary as they thought, it is not as painful, they didn’t
feel so crummy afterwards. The first time is the hardest. We have
had a campaign last year of "Bring a mate". We
have encouraged people to bring a buddy with them, not only less
lonely and frightening but also more friendly. It has been very
successful. It is slightly less hard for them to come back provided
we look after them. We don’t keep them waiting for two hours, we
don’t give them blood bruising on their arm. Most of these are preventable.
Our blood donors give blood between 1.7 and 2.1 times per year
(maximum is 4 times per year.) If we could increase the small percentage
of people who donate from giving once to twice a year this would
be a great increase in the supply. Plasma donors give 5 to 9 donations
a year (some every few weeks). Their blood is passed through an
apheresis machine to obtain the plasma with the remainder, red cells,
being returned to the donor. The donors can make up their plasma
quite quickly so that is why they can donate more frequently than
full blood donors. Especially for women who have a tendency to get
iron deficient and anaemic from loss of red cells. It is a good
way to get plasma without too much concern for the donor.
Q. Have there been any studies made of why generally donors
don’t give more than once or twice per year?
A. We know some of the reasons but not the individual responses.
Last year Sir Ninian Stephen handed down his review of the Red Cross
Blood Service and suggested that more research should be done on
blood donors, why people do and don’t donate. Interestingly, blood
donor research is one of the neglected areas of transfusion research.
I spend a lot of time on transfusion research, on people who receive
blood, potential benefits and hazards, but we know little about
the psychology of a blood donor and what motivates a blood donor.
Q. What percentage of plasma goes into Intragam?
A. I don’t know the answer. We know that for each batch of Intragam
it takes more than 10,000 blood donations. I don’t know how many
batches CSL produces each year but we collect in the order of one
million donations each year. A large proportion of the plasma collected
goes to CSL. I don’t know how much CSL allocated to Intragam.
Q. My Itragam was cut back a year ago. Is it likely to be cut
back again? After the cut back, I got worse.
A. I don’t know the answer. We don’t have enough Intragam to meet
all the needs. It is a balance between giving some people all the
Intragam they need and some people nothing which is obviously not
appropriate, and trying to give most of the people most of what
they need most of the time. That is not an easy balance. At the
same time the Blood Service has the need to try and work with people
and their doctors to determine the minium, amount to keep people
active and healthy.
Q. My doctor has communicated with the Blood Service about my
not getting adequate Intragam and has received no reply.
A. I am sorry to hear that. Could I suggest you ask your doctor
to write again. We are happy to review everybody’s request. I spend
part of my day in reviewing requests. I spend part of my day in
reviewing requests. For some people we don’t hear from their doctor,
for others we hear every few months, saying Mrs X is doing well
or Mr Y is not doing well. This communication is very helpful.
Q. Generally, are you seeing an improvement or a decline in
the situation?
A. I don’t know. It is in a constant state of flux. The demand
is increasing at the same time as the supply is increasing. It is
very hard to see which is predominating at any time.
Q. Why do people get Intragam at different periods?
A. We know that Intragam has a long half-life, about forty days.
So it is difficult to predict whether somebody would benefit from
a larger dose less often or a smaller dose more often. This has
to be worked out between a person and their doctor. Also it can
change with time. Some people improve and need less, some can get
worse and need more.
Q. I find it frustrating to go too frequently for the Intragam.
A. This is why communication is very important between the Blood
Service, doctors and patients. It is very individual. Some people
improve and can have the interval between Intragam treatment extended,
others get worse and may need the interval reduced.
Q. If a doctor supplies some objective evidence about the treatment,
what is the Blood Service response?
A. We do appreciate those who supply hard evidence but it still
means we don’t have enough Intragam.
Q. What has been the effect of the "Mad Cow" disease
on donations?
A. We expected to lose 5,000 donors in Victoria with the CJD deferral
introduced last year. In face we have been successful in replacing
most of those people but it has taken a lot of time, effort and
money. We have collected more blood last year than in the previous
year. The most useful donors are those who come year after year.
We know the donors, and regulars will have a lower rate of hepatitis
and HIV.
Q. I have a reaction to Intragam. Is it the plasma component
or something added?
A. There are very few things added. There is maltose, a kind of
sugar. About one percent is not immunoglobulin and occasionally
people will have reactions. Most of the reactions can be prevented
or reduced by slowing down the rate of infusion.
Q. Is oral rather than intravenous provision of Intragam possible?
A. It is unlikely because antibodies circulate in the blood stream
and their proteins would be destroyed if passed through the gastro/intestinal
system.
Q. Do you keep up with other countries?
A. We do. I used to work in the USA Red Cross in the IVIG use.
Australia has a middle ranking in the amount of IVIG used per capita.
USA uses about twice as much as we do and we use about twice as
much as the UK.
Q. How can we help with the blood donations?
A. Probably the most useful thing is to talk to your friends and
family about what you need for your treatment and say "It is
quite easy to be a blood donor. It is something most people can
do."
Q. Would you welcome correspondence from nurses involved in
Intragam treatment?
A. We are very interested in how people are doing as it helps us
to know how we are meeting the needs.
(Dr Erica Wood most kindly replaced our scheduled speaker, Dr Neil
Boyce, at very short notice. Dr Boyce unfortunately was ill and
could not attend.)
|